Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)-Reference-Cited by-同舟云学术

Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)

Published:2022-06-06 Issue:8 Volume:39 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Desideri Isacco,Lucidi Sara,Francolini Giulio,Meattini Icro,Ciccone Lucia Pia,Salvestrini Viola,Valzano Marianna,Morelli Ilaria^ORCID,Angelini Lucia,Scotti Vieri,Bonomo Pierluigi,Greto Daniela,Terziani Francesca,Becherini Carlotta,Visani Luca,Livi Lorenzo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-022-01723-x.pdf

Reference45 articles.

1. Cuzick J, Sestak I, Baum M, ATAC/LATTE investigators, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11:1135–41. https://doi.org/10.1016/S1470-2045(10)70257-6.

2. Regan MM, Neven P, Giobbie-Hurder A, et al. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1–98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncol. 2011;12:1101–8. https://doi.org/10.1016/S1470-2045(11)70270-4.

3. Ingle JN, Tu D, Pater JL, et al. Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial. Breast Cancer Res Treat. 2006;99:295–300. https://doi.org/10.1007/s10549-006-9207-y.

4. Howell A, Cuzick J, Baum M, ATAC Trialists’ Group, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment for breast cancer. Lancet. 2005;365:60–2. https://doi.org/10.1016/S0140-6736(04)17666-6.

5. Liana DC, Kenneth AW, Benjamin RS, et al. Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia. Patient Relat Outcome Meas. 2015;6:205–14. https://doi.org/10.2147/PROM.S47997.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms;Nutrients;2024-06-28

2. Integrating Therapies: A Rational, Personalised Approach to Metastatic Disease;Integrative Oncology in Breast Cancer Care;2023

3. ANTI INFLAMMATORY AND ANTIMICROBIAL ACTIVITY OF HALLOYSITE NANOTUBES INCORPORATED BROMELAIN NANOCOMPOSITE AGAINST WOUND PATHOGENS;INT J EARLY CHILD SP;2022